RHÖN-KLINIKUM AG / Key word(s): Final Results/Quarter Results28.04.2011 / 07:00Results for financial year 2010 * Further 13.4% increase in patient treatments is proof of the trust in thehigh quality of medical care offering.* Growth in revenues of 9.9% and in earnings of 10.2% in 2010 demonstratethe sustainability of growth course.* Occupation of new buildings in Gießen and Marburg in the first quarter of2011. The investment commitments there - EUR 260 million from shareholderfunds - were fully met. Gießen and Marburg are proof of investmentcapability and innovative strength.Q1 2011 results* Continued rise in patient numbers by 69,839 cases or 13.7% to a total of579,632 cases (previous year: 509,793 cases) underscores our good startinto the new financial year.* Revenues climbed by 3.7% to reach EUR 647.2 million.* Net consolidated profit rose by EUR 3.7 million or 10.8% to reach EUR38.0 million.* EBITDA rose by EUR 5.7 million or 7.8% to reach EUR 78.8 million.* EBIT improved by EUR 3.8 million or 8.1% to EUR 50.6 million.Forecast for the further course of 2011The Company confirms its forecast for 2011. Despite a challengingenvironment, the Company expects to generate revenues of roughly EUR 2.65billion, an EBITDA of EUR 340 million and a net consolidated profit ofapproximately EUR 160 million, with the last two figures potentiallyfluctuating within a range of plus or minus 5%.Bad Neustadt a. d. Saale/Frankfurt am Main, 28 April 2011At its annual Results Press Conference today, the Board of Management ofRHÖN-KLINIKUM AG will confirm the trend figures already published inFebruary. 'We can look back on a successful financial year 2010. 'Patientnumbers have grown once again', said Wolfgang Pföhler, chairman of theBoard of Management of RHÖN-KLINIKUM AG. 'We are proud of the achievementof our employees and facilities. The growing demand for our healthcareservices is proof of the trust people put in the high quality of ourmedical offering. We have succeeded in continuing our growth in both theoutpatient and inpatient area. Our revenue and earnings targets were met asexpected. We once again succeeded in expanding our market share in 2010.Our long-standing facilities report organic growth well above the emergingnational average. At the same time we stick to our policy of investing thelion's share of our corporate profit in our hospitals and MVZs, - some 70%of that profit is reinvested. That makes our investment ratio significantlyhigher than that of any public operator. The reliability of our businessmodel was once again demonstrated. We can thus present a thoroughlypositive result for financial year 2010', Pföhler said.Results for financial year 2010In 2010, a total of more than two million patients were treated in theGroup's facilities. During the same period, revenues rose to EUR 2.55billion. Net consolidated profit increased as forecast by 10.2% to EUR145.1 million. Compared with last year, EBITDA was raised by 8.2% to EUR307.3 million and EBIT by 8.7% to EUR 197.9 million. Operating cash flowsaw an increase of 7.4% to EUR 255.9 million.The 13.4% rise in patient treatments was 'proof of the great trust in thequality of our work'. With growth in revenues of 9.9% and in earnings of10.2% in 2010, RHÖN-KLINIKUM AG moreover demonstrated the sustainability ofits growth course - also in times of crisis. Pföhler gave assurance thatthis 'reliable' course would also be 'steadfastly' maintained in the newfinancial year.On 8 June 2011, the Board of Management and the Supervisory Board willpropose a dividend of EUR 0.37 (previous year: EUR 0.30) per ordinarynon-par share with dividend entitlement (DE 0007042301; 138,232,000 non-parshares).Jobs in 2010As at 31 December 2010, RHÖN-KLINIKUM AG employed a total of 38,058 peoplein ten federal states.That is 1176 more than in the previous year. Above all doctors and nursingstaff were added. In many regions, the Group's facilities have come to beamongst the largest employers.Q1 2011 resultsThe Management is pleased with the start the Company has made intofinancial year 2011. Already in the first three months, the Group treated579,632 patients (+ 13.7%). Revenues rose to EUR 647.2 million (+3.7%). Netconsolidated profit rose 10.8% to reach EUR 38.0 million.EBITDA climbed to EUR 78.8 million (+ 7.8%). EBIT stood at EUR 50.6million, which translates into a rise of 8.1% versus the previous year'slevel. As at 31 March 2011, the Group had 38,174 employees.'The good first-quarter figures provide a very good starting point forreliably reaching our forecast for full-year 2011', said Dr. Erik Hamann,the Company's CFO.To major projects were already successfully concluded in the first quarter.At the University Hospital of Gießen and Marburg two new buildings were putinto service. At both sites the moves were completed without any incidents.Outlook for 2011: Securing the future sustainability of good medical care is one of the keyaims pursued by the Group. Demographic trends and the related growing needfor high-quality medical care for the elderly present new challenges forthe healthcare system. 'We are committed to meeting these needs by creatingmedical care offerings tailored to the individual needs of patients. Wehave starting doing this by strengthening our medical care networks withinour Group, for example in acute geriatrics.The groundwork for this has been laid with the acquisition of the SalzeKlinik hospital and the integration of a geriatric focus within ourhospital network - an outstanding medical concept in which we are onceagain setting standards nationally. We are forging ahead with efforts toimplement viable and path-breaking service offerings.At the same time, we continue to be committed to seeing through ourdevelopment from classic hospital operator to integrated healthcareprovider. The emerging structural transformation shows that we have come agood way towards successfully completing the process begun two years ago:advances in medicine and medical technology are giving rise to more andmore opportunities for outpatient treatment. There is hardly any betterexample of how inpatient services are thus being shifted into theoutpatient segment than the specialist field of ophthalmology. Weidentified the opportunities it holds early on, and are able to offerpatients innovative care services after our market entry into the field ofophthalmology at the beginning of the year.Right now the basis is being created for new legislation governingoutpatient care', explained the chairman of the Board of Management,Wolfgang Pföhler. This new healthcare provision act has been prompted bythe shortage of doctors that is in the offing, especially in rural andstructurally weak regions.As one of the largest providers of healthcare in Germany, RHÖN-KLINIKUM AGwants to participate in shaping the required system change. And the Companyviews the integration of outpatient and inpatient care and the creation ofattractive working conditions for doctors designed to harmonise family andcareer as an important first step towards this goal.'Good health means quality of life, which is the highest human good. In2011 also, our objective is thus to offer generalised high-quality carethat is accessible and affordable for everyone', said Pföhler.Contact: Hans-Jürgen HeckHead of Group Press and Public RelationsSchlossplatz 197616 Bad Neustadt a. d. SaaleGermanyTel.: ++49 (0) 9771/ 65 - 1322Fax: ++49 (0) 9771/ 65 - 1820E-mail: hans-juergen.heck@rhoen-klinikum-ag.com RHÖN-KLINIKUM AG is one of the largest healthcare providers in Germany. Itscorporate objective is high-quality medical care for everyone. Currently,our Group counts 53 hospitals at 43 sites as well as 35 medical carecentres (MVZs) throughout Germany. We employ more than 38,000 persons. Infinancial year 2010, more than two million patients were treated in theGroup's facilities.Further information is available at: www.rhoen-klinikum-ag.com.End of Corporate News
28.04.2011 Dissemination of a Corporate News, transmitted by DGAP - acompany of EquityStory AG.The issuer is solely responsible for the content of this announcement.DGAP's Distribution Services include Regulatory Announcements,Financial/Corporate News and Press Releases.Media archive at www.dgap-medientreff.de and www.dgap.de
Language: English Company: RHÖN-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a.d.Saale Deutschland Phone: +49 (0)9771 - 65-0 Fax: +49 (0)9771 - 97 467 E-mail: rka@rhoen-klinikum-ag.com Internet: www.rhoen-klinikum-ag.com ISIN: DE0007042301 WKN: 704230 Listed: Regulierter Markt in Frankfurt (Prime Standard), München; Freiverkehr in Berlin, Düsseldorf, Hamburg, Stuttgart End of News DGAP News-Service 
 121729 28.04.2011